Search Results 861-870 of 16367 for pharmacogenetics
About this study. The purpose of this study is to assess the decision-making process in women who have Von Willebrand disease, regarding their attitudes and ...
The purpose of this study is to identify prognostic biomarkers of neuroendocrine carcinomas. Participation eligibility. Participant eligibility includes age, ...
ROCHESTER, Minn. — A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients with colorectal ...
Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...
About this study. The purpose of this study is to: To identify predictors of inferior overall survival in HES/IHE patients including molecular parameters ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
The purpose of this study is to develop and validate full gene-sequencing assays or known mutation sequencing assays for the evaluation of patients with ...
About this study. The purpose of this study is to gather initial data for pain biomarker discovery in humans with correlation to clinical outcomes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.